- Home
- MLP vs SAGE Comparison
MLP vs SAGE Comparison
Compare MLP & SAGE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLP
- SAGE
- Stock Information
- Founded
- MLP 1909
- SAGE 2010
- Country
- MLP United States
- SAGE United States
- Employees
- MLP N/A
- SAGE N/A
- Industry
- MLP Real Estate
- SAGE Biotechnology: Pharmaceutical Preparations
- Sector
- MLP Finance
- SAGE Health Care
- Exchange
- MLP Nasdaq
- SAGE Nasdaq
- Market Cap
- MLP 512.1M
- SAGE 462.2M
- IPO Year
- MLP 1972
- SAGE 2014
- Fundamental
- Price
- MLP $22.37
- SAGE $5.73
- Analyst Decision
- MLP
- SAGE Hold
- Analyst Count
- MLP 0
- SAGE 19
- Target Price
- MLP N/A
- SAGE $11.53
- AVG Volume (30 Days)
- MLP 20.1K
- SAGE 1.3M
- Earning Date
- MLP 11-14-2024
- SAGE 02-12-2025
- Dividend Yield
- MLP N/A
- SAGE N/A
- EPS Growth
- MLP N/A
- SAGE N/A
- EPS
- MLP N/A
- SAGE N/A
- Revenue
- MLP $12,196,000.00
- SAGE $106,399,000.00
- Revenue This Year
- MLP N/A
- SAGE N/A
- Revenue Next Year
- MLP N/A
- SAGE $122.66
- P/E Ratio
- MLP N/A
- SAGE N/A
- Revenue Growth
- MLP 34.84
- SAGE 837.60
- 52 Week Low
- MLP $15.57
- SAGE $4.62
- 52 Week High
- MLP $26.46
- SAGE $28.26
- Technical
- Relative Strength Index (RSI)
- MLP 46.61
- SAGE 52.91
- Support Level
- MLP $21.11
- SAGE $5.09
- Resistance Level
- MLP $23.41
- SAGE $5.77
- Average True Range (ATR)
- MLP 0.69
- SAGE 0.40
- MACD
- MLP 0.03
- SAGE 0.06
- Stochastic Oscillator
- MLP 54.78
- SAGE 81.44
About MLP Maui Land & Pineapple Company Inc.
Maui Land & Pineapple Co Inc is a landholding and operating company. ML&P owns, develops, sells, and manages residential, resort, commercial, agricultural, and industrial real estate. It operates in three segments: Land Development & Sales: , which includes land planning and entitlement, development, and sales activities.; Leasing operations include residential, resort, commercial, agricultural, industrial land and property leases; and Resort Amenities segment, which include a membership program that provides certain benefits and privileges within the Kapalua Resort for its members. The majority of its revenue is derived from the Leasing segment. Leasing revenue is generated from restaurants, retail outlets, office buildings, warehouses, and other resort activities.
About SAGE Sage Therapeutics Inc.
Sage Therapeutics Inc is a clinical-stage biopharmaceutical company focused on brain health medicines. The company is targeting diseases and disorders of the brain with three key focus areas: depression, neurology and neuropsychiatry; also targeting two critical central nervous system, or CNS, receptor systems, GABA and NMDA. Its products ZURZUVAE is a medicine for the treatment of postpartum depression, or PPD, in adults, and ZULRESSO is a CIV injection for the treatment of postpartum depression in individuals 15 years old and older. It also has other drugs in its pipeline such as SAGE-324, Dalzanemdor (SAGE-718) among others.